Viemed Healthcare Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Viemed Healthcare Inc 's ROA in the second quarter of 2026?
Viemed Healthcare Inc achieved a return on average assets (ROA) of 7.51 % in its second quarter of 2026, which is below Viemed Healthcare Inc 's average return on assets, which stands at 10.72%.

ROA fell compared to the first quarter of 2026, despite the net income growth of 6.89% from the first quarter of 2026.

However, within the Healthcare sector 124 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 786, from total ROA ranking in the first quarter of 2026 at 892.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	10.63 %	10.83 %	15.79 %	21.56 %	13.84 %
Y / Y Net Income Change	-10.77 %	0.11 %	31.46 %	-7.81 %	120.04 %
Net Income (TTM) in million	15	15	15	14	14
Return On Assets (TTM)	7.51 %	7.88 %	8.08 %	7.62 %	8.18 %
VMD's Total Ranking	# 786	# 892	# 829	# 790	# 863
Total Assets (TTM) in million	204	197	199	199	185
Seq. Total Assets Change	3.48 %	-0.9 %	-0.08 %	7.97 %	3.66 %
Seq. Net Income Change	6.89 %	-53.35 %	61.56 %	10.77 %	19.93 %

VMD's 5 Years Annual ROA >> Back to VMD Management Effectiveness >> Compare VMD ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 14
Sector	# 125
Overall	# 831

Return On Assets Statistics
High	Average	Low
31.21 %	10.72 %	5.01 %
(Jun 30 2020)		(Mar 31 2023)

Financial Statements
Viemed Healthcare Inc 's Assets	$ 204 million	VMD's Balance sheet
Viemed Healthcare Inc 's Income	$ 3 million	Quarterly VMD's Income Statement
VMD's Income by Division		See VMD's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	15.79 %	12.95 %	32.71 %	1.26 %	7.95 %
Total Assets in million	199	172	152	115	113
Y / Y Net Income Change	34.77 %	11.38 %	64.63 %	-31.82 %	-71.06 %
Net Income in million	15	11	10	6	9
Annual Return On Assets	7.72 %	6.63 %	6.73 %	5.42 %	8.05 %

VMD's 5 Years Annual ROA >> Back to VMD Management Effectiveness >> Compare VMD ROA to its Competitors

Comment on VMD's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 7.72 % compared to prior year, due to annual net income growth of 34.77 % to $15.38 million, while value of Viemed Healthcare Inc 's overall assets grew just by 15.79 % to $199.15 million, compared to $199.15 a year before.

More Return On Assets Ratios
VMD's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
VMD's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for VMD's Competitors
Subscribers only: Roa for Viemed Healthcare Inc 's Suppliers
Subscribers only: Return On Assets for VMD's Customers

You may also want to know
VMD's Roi	VMD's Inventory Turnover Ratio	VMD's Growth Rates	VMD's Dividend Comparisons
	VMD's Profitability Ratios	VMD's Asset Turnover Ratio	VMD's Dividend Growth
VMD's Roe	VMD's Valuation Ratios	VMD's Financial Strength Ratios	VMD's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Zevra Therapeutics Inc	20.39 %
Iradimed Corporation	20.36 %
Protalix Biotherapeutics inc	20.09 %
Pro dex Inc	19.87 %
Electromed Inc	19.39 %
United Therapeutics Corporation	17.98 %
Resmed Inc	17.80 %
Krystal Biotech Inc	17.65 %
Chemed Corporation	17.52 %
Zoetis Inc	17.19 %
Vertex Pharmaceuticals Inc	16.88 %
Halozyme Therapeutics Inc	16.55 %
Alnylam Pharmaceuticals Inc	15.76 %
Intuitive Surgical Inc	15.63 %
Healthcare Services Group Inc	15.21 %
Inspire Medical Systems inc	15.21 %
Dexcom Inc	14.87 %
Neurocrine Biosciences Inc	14.73 %
Entera Bio Ltd	14.60 %
Standard Biotools Inc	14.31 %
Arcutis Biotherapeutics Inc	14.23 %
Harmony Biosciences Holdings inc	14.15 %
Biolife Solutions Inc	14.09 %
Aveanna Healthcare Holdings Inc	13.82 %
West Pharmaceutical Services Inc	13.64 %
Medinotec Inc	13.38 %
Puma Biotechnology Inc	13.28 %
Sbc Medical Group Holdings Incorporated	13.26 %
Alpha Pro Tech Ltd	13.17 %
Illumina Inc	12.68 %

Date modified: 2026-09-12T19:01:19+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.